Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Steris Corp (STE)

Steris Corp (STE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Wall Street Bullish or Bearish on STERIS Stock?

With a market cap of $24.6 billion, STERIS plc (STE) is a global provider of infection prevention products and services, operating through its Healthcare, Applied Sterilization Technologies (AST), and Life Sciences segments. It serves hospitals, healthcare providers, and pharmaceutical manufacturers with a broad portfolio of equipment, consumables, and technical services designed to ensure safety, sterility, and compliance worldwide.

Shares of the Mentor, Ohio-based company have outpaced the broader market over the past 52 weeks. STE stock has returned 13.5% over this time frame, while the broader S&P 500 Index ($SPX) has gained 11.7%. However, shares of the company have declined marginally...

Fundamentals

See More
  • Market Capitalization, $K 24,634,476
  • Shares Outstanding, K 98,075
  • Annual Sales, $ 5,460 M
  • Annual Income, $ 614,640 K
  • EBIT $ 1,049 M
  • EBITDA $ 1,526 M
  • 60-Month Beta 1.03
  • Price/Sales 4.48
  • Price/Cash Flow 17.49
  • Price/Book 3.41

Options Overview Details

View History
  • Implied Volatility 20.80% (+0.37%)
  • Historical Volatility 32.34%
  • IV Percentile 34%
  • IV Rank 15.18%
  • IV High 43.38% on 04/07/25
  • IV Low 16.76% on 08/20/25
  • Expected Move (DTE 28) 14.26 (5.69%)
  • Put/Call Vol Ratio 0.50
  • Today's Volume 9
  • Volume Avg (30-Day) 114
  • Put/Call OI Ratio 1.93
  • Today's Open Interest 2,044
  • Open Int (30-Day) 1,692
  • Expected Range 236.39 to 264.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.88
  • Number of Estimates 4
  • High Estimate 2.96
  • Low Estimate 2.85
  • Prior Year 2.74
  • Growth Rate Est. (year over year) +5.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
226.41 +10.71%
on 02/05/26
268.74 -6.73%
on 02/03/26
-7.34 (-2.85%)
since 01/20/26
3-Month
226.41 +10.71%
on 02/05/26
269.44 -6.97%
on 01/16/26
-6.33 (-2.46%)
since 11/20/25
52-Week
204.90 +22.33%
on 04/09/25
269.44 -6.97%
on 01/16/26
+29.86 (+13.52%)
since 02/20/25

Most Recent Stories

More News
Is Wall Street Bullish or Bearish on STERIS Stock?

Despite STERIS' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

XLV : 156.82 (-0.28%)
STE : 250.65 (-0.21%)
$SPX : 6,909.51 (+0.69%)
The 5 Most Interesting Analyst Questions From STERIS’s Q4 Earnings Call

The 5 Most Interesting Analyst Questions From STERIS’s Q4 Earnings Call

STE : 250.65 (-0.21%)
STERIS (NYSE:STE) Beats Q4 CY2025 Sales Expectations

STERIS (NYSE:STE) Beats Q4 CY2025 Sales Expectations

STE : 250.65 (-0.21%)
STERIS Announces Financial Results for Fiscal 2026 Third Quarter

Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.96; adjusted EPS increased to $2.53 Fiscal...

STE : 250.65 (-0.21%)
What To Expect From STERIS’s (STE) Q4 Earnings

What To Expect From STERIS’s (STE) Q4 Earnings

STE : 250.65 (-0.21%)
STERIS Announces Dividend of $0.63 per share

DUBLIN, IRELAND, Jan. 28, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share....

STE : 250.65 (-0.21%)
1 Profitable Stock with Exciting Potential and 2 Facing Challenges

1 Profitable Stock with Exciting Potential and 2 Facing Challenges

VZ : 49.25 (+1.25%)
STE : 250.65 (-0.21%)
MOH : 151.00 (+1.86%)
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky

1 Unpopular Stock That Should Get More Attention and 2 We Find Risky

STE : 250.65 (-0.21%)
AIN : 59.44 (-0.03%)
BX : 121.27 (-3.57%)
STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026

DUBLIN, IRELAND, Jan. 21, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 third quarter...

STE : 250.65 (-0.21%)
METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

Mettler-Toledo International Inc. (NYSE: MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years...

STE : 250.65 (-0.21%)
MTD : 1,377.55 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS...

See More

Key Turning Points

3rd Resistance Point 260.99
2nd Resistance Point 258.28
1st Resistance Point 254.47
Last Price 250.65
1st Support Level 247.95
2nd Support Level 245.24
3rd Support Level 241.43

See More

52-Week High 269.44
Last Price 250.65
Fibonacci 61.8% 244.79
Fibonacci 50% 237.17
Fibonacci 38.2% 229.55
52-Week Low 204.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar